SUSIE HOWARD

S. 391/HR. 1321 - the "Healthy American's Act" regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR 5809 the "Safe Drug Disposal Act of 2010" All provisions regarding permitting an ultimate user who has lawfully obtained a controlled substance to deliver such substance to another person for purpose of disposal. S. 3397 the 'Secure and Responsible Drug Disposal Act of 2010" All provisions regarding allowing an ultimate user of a controlled substance who has lawfully obtained such substance to deliver that substance to another person for disposal,

S. 391/HR. 1321 - the "Healthy American's Act" regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety.

H.R. 3590- the "Patient Protection and Affordable Care Act" regarding the role of pharmacists and the practice of pharmacy in healthcare. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1586- the "FAA Air Transportation Modernization and Safety Improvement Act" -Title II- all provisions relating to State Fiscal Relief and other provisions. Extend through the first three quarters of 2011 the Federal Medicaid Assistance Percentage (FMAP). Amend title XIX of the Social Security Act to include Medicaid coverage in the Medicaid average manufacturer price any drug that is an inhalation, infusion, instilled, implanted, or injectable drug that is not generally dispensed through a retail pharmacy. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 5597 - all provisions regarding establishing a Medicare patient IVIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP).

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program.

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 4851, the "Continuing Extension Act of 2010," - section 4 - provisions relating to amending title XVIII (Medicare) of the Social Security Act to extend through May 31, 2010, the 0% update to the conversion factor in the Medicare physician payment computation. HR 5597 - all provisions regarding establishing a Medicare patient NIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP). HR 3590 - the Patient Protection and Affordable Care Act.

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 4851, the "Continuing Extension Act of 2010," - section 4 - provisions relating to amending title XVIII (Medicare) of the Social Security Act to extend through May 31, 2010, the 0% update to the conversion factor in the Medicare physician payment computation. HR 5597 - all provisions regarding establishing a Medicare patient NIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP). HR 3590 - the Patient Protection and Affordable Care Act.

H.R. 3590- the "Patient Protection and Affordable Care Act" regarding the role of pharmacists and the practice of pharmacy in healthcare. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1586- the "FAA Air Transportation Modernization and Safety Improvement Act" -Title II- all provisions relating to State Fiscal Relief and other provisions. Extend through the first three quarters of 2011 the Federal Medicaid Assistance Percentage (FMAP). Amend title XIX of the Social Security Act to include Medicaid coverage in the Medicaid average manufacturer price any drug that is an inhalation, infusion, instilled, implanted, or injectable drug that is not generally dispensed through a retail pharmacy. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 5597 - all provisions regarding establishing a Medicare patient IVIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP).

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program.

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program.

H.R. 3590- the "Patient Protection and Affordable Care Act" regarding the role of pharmacists and the practice of pharmacy in healthcare. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1586- the "FAA Air Transportation Modernization and Safety Improvement Act" -Title II- all provisions relating to State Fiscal Relief and other provisions. Extend through the first three quarters of 2011 the Federal Medicaid Assistance Percentage (FMAP). Amend title XIX of the Social Security Act to include Medicaid coverage in the Medicaid average manufacturer price any drug that is an inhalation, infusion, instilled, implanted, or injectable drug that is not generally dispensed through a retail pharmacy. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 5597 - all provisions regarding establishing a Medicare patient IVIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP).

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 4851, the "Continuing Extension Act of 2010," - section 4 - provisions relating to amending title XVIII (Medicare) of the Social Security Act to extend through May 31, 2010, the 0% update to the conversion factor in the Medicare physician payment computation. HR 5597 - all provisions regarding establishing a Medicare patient NIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP). HR 3590 - the Patient Protection and Affordable Care Act.

HR 3590, the Patient Protection and Affordable Care Act- regarding redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies- as related to AMPs Federal Upper Limits (FULs), regarding expanding medication therapy management (MTM) services provided by pharmacists and expanding home infusion in Medicare to cover the supplies, equipment and services. H.R. 3962, the Affordable Health Care for America Act- regarding redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies- as related to AMPs Federal Upper Limits (FULs), regarding expanding medication therapy management (MTM) services provided by pharmacists and expanding home infusion in Medicare to cover the supplies, equipment and services. HR 2350 the Preserving Patient Access to Primary Care Act of 2009 all provisions; regarding increasing the number of primary care physicians and primary care providers, such as nurse practitioners and physician assistants, to improve patient access to primary care services.

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program.

H.R. 3590- the "Patient Protection and Affordable Care Act" regarding the role of pharmacists and the practice of pharmacy in healthcare. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1586- the "FAA Air Transportation Modernization and Safety Improvement Act" -Title II- all provisions relating to State Fiscal Relief and other provisions. Extend through the first three quarters of 2011 the Federal Medicaid Assistance Percentage (FMAP). Amend title XIX of the Social Security Act to include Medicaid coverage in the Medicaid average manufacturer price any drug that is an inhalation, infusion, instilled, implanted, or injectable drug that is not generally dispensed through a retail pharmacy. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 5597 - all provisions regarding establishing a Medicare patient IVIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP).

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 4851, the "Continuing Extension Act of 2010," - section 4 - provisions relating to amending title XVIII (Medicare) of the Social Security Act to extend through May 31, 2010, the 0% update to the conversion factor in the Medicare physician payment computation. HR 5597 - all provisions regarding establishing a Medicare patient NIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP). HR 3590 - the Patient Protection and Affordable Care Act.

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 4851, the "Continuing Extension Act of 2010," - section 4 - provisions relating to amending title XVIII (Medicare) of the Social Security Act to extend through May 31, 2010, the 0% update to the conversion factor in the Medicare physician payment computation. HR 5597 - all provisions regarding establishing a Medicare patient NIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP). HR 3590 - the Patient Protection and Affordable Care Act.

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 4851, the "Continuing Extension Act of 2010," - section 4 - provisions relating to amending title XVIII (Medicare) of the Social Security Act to extend through May 31, 2010, the 0% update to the conversion factor in the Medicare physician payment computation. HR 5597 - all provisions regarding establishing a Medicare patient NIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP). HR 3590 - the Patient Protection and Affordable Care Act.

H.R. 3590- the "Patient Protection and Affordable Care Act" regarding the role of pharmacists and the practice of pharmacy in healthcare. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1586- the "FAA Air Transportation Modernization and Safety Improvement Act" -Title II- all provisions relating to State Fiscal Relief and other provisions. Extend through the first three quarters of 2011 the Federal Medicaid Assistance Percentage (FMAP). Amend title XIX of the Social Security Act to include Medicaid coverage in the Medicaid average manufacturer price any drug that is an inhalation, infusion, instilled, implanted, or injectable drug that is not generally dispensed through a retail pharmacy. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 5597 - all provisions regarding establishing a Medicare patient IVIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP).

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 4851, the "Continuing Extension Act of 2010," - section 4 - provisions relating to amending title XVIII (Medicare) of the Social Security Act to extend through May 31, 2010, the 0% update to the conversion factor in the Medicare physician payment computation. HR 5597 - all provisions regarding establishing a Medicare patient NIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP). HR 3590 - the Patient Protection and Affordable Care Act.

H.R. 3590- the "Patient Protection and Affordable Care Act" regarding the role of pharmacists and the practice of pharmacy in healthcare. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1586- the "FAA Air Transportation Modernization and Safety Improvement Act" -Title II- all provisions relating to State Fiscal Relief and other provisions. Extend through the first three quarters of 2011 the Federal Medicaid Assistance Percentage (FMAP). Amend title XIX of the Social Security Act to include Medicaid coverage in the Medicaid average manufacturer price any drug that is an inhalation, infusion, instilled, implanted, or injectable drug that is not generally dispensed through a retail pharmacy. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 5597 - all provisions regarding establishing a Medicare patient IVIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP).

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program.

S. 391/HR. 1321 - the "Healthy American's Act" regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR 5809 the "Safe Drug Disposal Act of 2010" All provisions regarding permitting an ultimate user who has lawfully obtained a controlled substance to deliver such substance to another person for purpose of disposal. S. 3397 the 'Secure and Responsible Drug Disposal Act of 2010" All provisions regarding allowing an ultimate user of a controlled substance who has lawfully obtained such substance to deliver that substance to another person for disposal,

S. 391/HR. 1321 - the "Healthy American's Act" regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety.

HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices.

HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

HR 3590 - the Patient Protection and Affordable Care Act. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety.

S. 391/HR. 1321 - the "Healthy American's Act" regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR 5809 the "Safe Drug Disposal Act of 2010" All provisions regarding permitting an ultimate user who has lawfully obtained a controlled substance to deliver such substance to another person for purpose of disposal. S. 3397 the 'Secure and Responsible Drug Disposal Act of 2010" All provisions regarding allowing an ultimate user of a controlled substance who has lawfully obtained such substance to deliver that substance to another person for disposal,

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

S. 391/HR. 1321 - the "Healthy American's Act" regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR 5809 the "Safe Drug Disposal Act of 2010" All provisions regarding permitting an ultimate user who has lawfully obtained a controlled substance to deliver such substance to another person for purpose of disposal. S. 3397 the 'Secure and Responsible Drug Disposal Act of 2010" All provisions regarding allowing an ultimate user of a controlled substance who has lawfully obtained such substance to deliver that substance to another person for disposal,

HR 3590 - the Patient Protection and Affordable Care Act. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety.

S. 391/HR. 1321 - the "Healthy American's Act" regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety.

HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

H.R. 3590- the "Patient Protection and Affordable Care Act" regarding the role of pharmacists and the practice of pharmacy in healthcare. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1586- the "FAA Air Transportation Modernization and Safety Improvement Act" -Title II- all provisions relating to State Fiscal Relief and other provisions. Extend through the first three quarters of 2011 the Federal Medicaid Assistance Percentage (FMAP). Amend title XIX of the Social Security Act to include Medicaid coverage in the Medicaid average manufacturer price any drug that is an inhalation, infusion, instilled, implanted, or injectable drug that is not generally dispensed through a retail pharmacy. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 5597 - all provisions regarding establishing a Medicare patient IVIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP).

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program.

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 4851, the "Continuing Extension Act of 2010," - section 4 - provisions relating to amending title XVIII (Medicare) of the Social Security Act to extend through May 31, 2010, the 0% update to the conversion factor in the Medicare physician payment computation. HR 5597 - all provisions regarding establishing a Medicare patient NIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP). HR 3590 - the Patient Protection and Affordable Care Act.

S. 391/HR. 1321 - the "Healthy American's Act" regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR 5809 the "Safe Drug Disposal Act of 2010" All provisions regarding permitting an ultimate user who has lawfully obtained a controlled substance to deliver such substance to another person for purpose of disposal. S. 3397 the 'Secure and Responsible Drug Disposal Act of 2010" All provisions regarding allowing an ultimate user of a controlled substance who has lawfully obtained such substance to deliver that substance to another person for disposal,

H.R. 3590- the "Patient Protection and Affordable Care Act" regarding the role of pharmacists and the practice of pharmacy in healthcare. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1586- the "FAA Air Transportation Modernization and Safety Improvement Act" -Title II- all provisions relating to State Fiscal Relief and other provisions. Extend through the first three quarters of 2011 the Federal Medicaid Assistance Percentage (FMAP). Amend title XIX of the Social Security Act to include Medicaid coverage in the Medicaid average manufacturer price any drug that is an inhalation, infusion, instilled, implanted, or injectable drug that is not generally dispensed through a retail pharmacy. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 5597 - all provisions regarding establishing a Medicare patient IVIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP).

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 4851, the "Continuing Extension Act of 2010," - section 4 - provisions relating to amending title XVIII (Medicare) of the Social Security Act to extend through May 31, 2010, the 0% update to the conversion factor in the Medicare physician payment computation. HR 5597 - all provisions regarding establishing a Medicare patient NIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP). HR 3590 - the Patient Protection and Affordable Care Act.

S. 391/HR. 1321 - the "Healthy American's Act" regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety.

S. 391/HR. 1321 - the "Healthy American's Act" regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR 5809 the "Safe Drug Disposal Act of 2010" All provisions regarding permitting an ultimate user who has lawfully obtained a controlled substance to deliver such substance to another person for purpose of disposal. S. 3397 the 'Secure and Responsible Drug Disposal Act of 2010" All provisions regarding allowing an ultimate user of a controlled substance who has lawfully obtained such substance to deliver that substance to another person for disposal,

HR 3590 - the Patient Protection and Affordable Care Act. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety.

S. 391/HR. 1321 - the "Healthy American's Act" regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR 5809 the "Safe Drug Disposal Act of 2010" All provisions regarding permitting an ultimate user who has lawfully obtained a controlled substance to deliver such substance to another person for purpose of disposal. S. 3397 the 'Secure and Responsible Drug Disposal Act of 2010" All provisions regarding allowing an ultimate user of a controlled substance who has lawfully obtained such substance to deliver that substance to another person for disposal,

S. 391/HR. 1321 - the "Healthy American's Act" regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety.

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program.

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 4851, the "Continuing Extension Act of 2010," - section 4 - provisions relating to amending title XVIII (Medicare) of the Social Security Act to extend through May 31, 2010, the 0% update to the conversion factor in the Medicare physician payment computation. HR 5597 - all provisions regarding establishing a Medicare patient NIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP). HR 3590 - the Patient Protection and Affordable Care Act.

H.R. 3590- the "Patient Protection and Affordable Care Act" regarding the role of pharmacists and the practice of pharmacy in healthcare. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1586- the "FAA Air Transportation Modernization and Safety Improvement Act" -Title II- all provisions relating to State Fiscal Relief and other provisions. Extend through the first three quarters of 2011 the Federal Medicaid Assistance Percentage (FMAP). Amend title XIX of the Social Security Act to include Medicaid coverage in the Medicaid average manufacturer price any drug that is an inhalation, infusion, instilled, implanted, or injectable drug that is not generally dispensed through a retail pharmacy. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 5597 - all provisions regarding establishing a Medicare patient IVIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP).

H.R. 3590- the "Patient Protection and Affordable Care Act" regarding the role of pharmacists and the practice of pharmacy in healthcare. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1586- the "FAA Air Transportation Modernization and Safety Improvement Act" -Title II- all provisions relating to State Fiscal Relief and other provisions. Extend through the first three quarters of 2011 the Federal Medicaid Assistance Percentage (FMAP). Amend title XIX of the Social Security Act to include Medicaid coverage in the Medicaid average manufacturer price any drug that is an inhalation, infusion, instilled, implanted, or injectable drug that is not generally dispensed through a retail pharmacy. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 5597 - all provisions regarding establishing a Medicare patient IVIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP).

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 4851, the "Continuing Extension Act of 2010," - section 4 - provisions relating to amending title XVIII (Medicare) of the Social Security Act to extend through May 31, 2010, the 0% update to the conversion factor in the Medicare physician payment computation. HR 5597 - all provisions regarding establishing a Medicare patient NIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP). HR 3590 - the Patient Protection and Affordable Care Act.

HR 3590, the Patient Protection and Affordable Care Act- regarding redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies- as related to AMPs Federal Upper Limits (FULs), regarding expanding medication therapy management (MTM) services provided by pharmacists and expanding home infusion in Medicare to cover the supplies, equipment and services. H.R. 3962, the Affordable Health Care for America Act- regarding redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies- as related to AMPs Federal Upper Limits (FULs), regarding expanding medication therapy management (MTM) services provided by pharmacists and expanding home infusion in Medicare to cover the supplies, equipment and services. HR 2350 the Preserving Patient Access to Primary Care Act of 2009 all provisions; regarding increasing the number of primary care physicians and primary care providers, such as nurse practitioners and physician assistants, to improve patient access to primary care services.

HR 3590, the Patient Protection and Affordable Care Act- regarding redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies- as related to AMPs Federal Upper Limits (FULs), regarding expanding medication therapy management (MTM) services provided by pharmacists and expanding home infusion in Medicare to cover the supplies, equipment and services. H.R. 3962, the Affordable Health Care for America Act- regarding redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies- as related to AMPs Federal Upper Limits (FULs), regarding expanding medication therapy management (MTM) services provided by pharmacists and expanding home infusion in Medicare to cover the supplies, equipment and services. HR 2350 the Preserving Patient Access to Primary Care Act of 2009 all provisions; regarding increasing the number of primary care physicians and primary care providers, such as nurse practitioners and physician assistants, to improve patient access to primary care services.

H.R. 1173 the Organized Retail Crime Act of 2009 all provisions, regarding amending title 18 of the United States Criminal Code to include organized retail crime and imposing requirements on on-line marketplaces to aid in criminal investigations; S. 470 the Combating Organized Retail Crime Act of 2009 all provisions, regarding amending the criminal code and expanding the definition of transporting and selling stolen goods from a physical or on-line marketplace; H.R. 1166 the E-Fencing Enforcement Act of 2009 all provisions, regarding amending the criminal code to impose duty on on-line marketplaces to retain contact information on high volume sellers and disclose that information when evidence is presented by law enforcement regarding stolen merchandise.

HR. 1173 the Organized Retail Crime Act of 2009 all provisions, regarding amending title 18 of the United States Criminal Code to include organized retail crime and imposing requirements on on-line marketplaces to facilitate criminal investigations. S. 470 the Combating Organized Retail Crime Act of 2009 all provisions, regarding amending the criminal code and expanding the definition of transporting and selling stolen goods from a physical or on-line marketplace. HR. 1166 the E-Fencing Enforcement Act of 2009 all provisions, regarding amending the criminal code to impose duty on on-line marketplaces to retain contact information on high volume sellers and disclose that information when evidence is presented by law enforcement that the merchandise is stolen.

H.R. 1173 the Organized Retail Crime Act of 2009 all provisions, regarding amending title 18 of the United States Criminal Code to include organized retail crime and imposing requirements on on-line marketplaces to aid in criminal investigations; S. 470 the Combating Organized Retail Crime Act of 2009 all provisions, regarding amending the criminal code and expanding the definition of transporting and selling stolen goods from a physical or on-line marketplace; H.R. 1166 the E-Fencing Enforcement Act of 2009 all provisions, regarding amending the criminal code to impose duty on on-line marketplaces to retain contact information on high volume sellers and disclose that information when evidence is presented by law enforcement regarding stolen merchandise.

HR. 1173 the Organized Retail Crime Act of 2009 all provisions, regarding amending title 18 of the United States Criminal Code to include organized retail crime and imposing requirements on on-line marketplaces to facilitate criminal investigations. S. 470 the Combating Organized Retail Crime Act of 2009 all provisions, regarding amending the criminal code and expanding the definition of transporting and selling stolen goods from a physical or on-line marketplace. HR. 1166 the E-Fencing Enforcement Act of 2009 all provisions, regarding amending the criminal code to impose duty on on-line marketplaces to retain contact information on high volume sellers and disclose that information when evidence is presented by law enforcement that the merchandise is stolen.

S. 182/HR. 12 the Paycheck Fairness Act all provisions, regarding amending the Fair Labor Standards Act to provide more effective remedies to victims of discrimination in the payment of wages on the basis of sex and other purposes. HR. 1409/S. 560 the Employee Free Choice Act all provisions, regarding amending the National Labor Relations Act to establish a system that enables employees to form, join, or assist labor organizations and to provide for mandatory injunctions for unfair labor practices during organizing efforts.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. HR. 1256 the Family Smoking Prevention and Tobacco Control Act. Title II provisions relating to labeling and marketing of tobacco products, provisions relating to labeling and marketing of smokeless tobacco products, Title III provisions relating to the labeling, recordkeeping and records inspection of tobacco products. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

H.R. 1 the American Recovery and Reinvestment Act of 2009- Title IV, all provisions relating to Health Information Technology, Title V, all provisions relating to Medicaid FMAP; S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; H.R. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE; Medicaid reimbursement for generic drugs relating to accurately defining Average Manufacturers Price (AMP) to reflect purchase price of retail pharmacies to ensure appropriate reimbursement no specific legislation; S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States; S. 525/H.R. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions regarding amending the federal food, drug and cosmetic act to allow the importation of prescription drugs by pharmacies; MedGuides regarding improvement needed to the Medication Guide Program no specific legislation; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish a workable rule that would allow for electronic prescribing of controlled substances no specific legislation; H.R. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to drug and device safety; H.R. 570 the Protecting Patients and Health Care Act of 2009 all provisions regarding nullifying regulations issued by the Secretary of Health and Human Services regarding conscience clause protections for health care workers and facilities; H.R. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals; S. 726/H.R. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals.

S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. HR. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE. S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug, and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR. 806 the TRICARE Mail Order Pharmacy Pilot Program Act, all provisions; regarding establishing a mail-order pharmacy pilot program for TRICAREe beneficiaries.

S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. HR. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE. Medicaid reimbursement for generic drugs relating to redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies- as related to AMPs Federal Upper Limits (FULs) no specific legislation. S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug, and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States. S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR. 806 the Tricare Mail Order Pharmacy Pilot Program Act, all provisions; regarding establishing a mail-order pharmacy pilot program for Tricare beneficiaries.

S. 391/HR. 1321 - the "Healthy American's Act" regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. HR. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE. S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug, and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR. 806 the Tricare Mail Order Pharmacy Pilot Program Act, all provisions; regarding establishing a mail-order pharmacy pilot program for Tricare beneficiaries.

H.R. 1 the American Recovery and Reinvestment Act of 2009- Title IV, all provisions relating to Health Information Technology, Title V, all provisions relating to Medicaid FMAP; S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; H.R. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE; Medicaid reimbursement for generic drugs relating to accurately defining Average Manufacturers Price (AMP) to reflect purchase price of retail pharmacies to ensure appropriate reimbursement no specific legislation; S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States; S. 525/H.R. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions regarding amending the federal food, drug and cosmetic act to allow the importation of prescription drugs by pharmacies; MedGuides regarding improvement needed to the Medication Guide Program no specific legislation; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish a workable rule that would allow for electronic prescribing of controlled substances no specific legislation; H.R. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to drug and device safety; H.R. 570 the Protecting Patients and Health Care Act of 2009 all provisions regarding nullifying regulations issued by the Secretary of Health and Human Services regarding conscience clause protections for health care workers and facilities; H.R. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals; S. 726/H.R. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals.

S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. HR. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE. S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug, and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR. 806 the TRICARE Mail Order Pharmacy Pilot Program Act, all provisions; regarding establishing a mail-order pharmacy pilot program for TRICAREe beneficiaries.

S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. HR. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE. Medicaid reimbursement for generic drugs relating to redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies- as related to AMPs Federal Upper Limits (FULs) no specific legislation. S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug, and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States. S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR. 806 the Tricare Mail Order Pharmacy Pilot Program Act, all provisions; regarding establishing a mail-order pharmacy pilot program for Tricare beneficiaries.

S. 391/HR. 1321 - the "Healthy American's Act" regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities. HR. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE. S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug, and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States. S. 1232/S. 525/HR. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions; regarding amending the federal food, drug, and cosmetic act to allow the importation of prescription drugs by pharmacies. MedGuides regarding improvement needed to the Medication Guide Program no specific legislation. Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish rules that would allow for electronic prescribing of controlled substances no specific legislation. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to this title on drug and device safety. HR. 806 the Tricare Mail Order Pharmacy Pilot Program Act, all provisions; regarding establishing a mail-order pharmacy pilot program for Tricare beneficiaries.

S. 182/HR. 12 the Paycheck Fairness Act all provisions, regarding amending the Fair Labor Standards Act to provide more effective remedies to victims of discrimination in the payment of wages on the basis of sex and other purposes. HR. 1409/S. 560 the Employee Free Choice Act all provisions, regarding amending the National Labor Relations Act to establish a system that enables employees to form, join, or assist labor organizations and to provide for mandatory injunctions for unfair labor practices during organizing efforts.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. HR. 1256 the Family Smoking Prevention and Tobacco Control Act. Title II provisions relating to labeling and marketing of tobacco products, provisions relating to labeling and marketing of smokeless tobacco products, Title III provisions relating to the labeling, recordkeeping and records inspection of tobacco products. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

H.R. 1 the American Recovery and Reinvestment Act of 2009- Title IV, all provisions relating to Health Information Technology, Title V, all provisions relating to Medicaid FMAP; S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; H.R. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE; Medicaid reimbursement for generic drugs relating to accurately defining Average Manufacturers Price (AMP) to reflect purchase price of retail pharmacies to ensure appropriate reimbursement no specific legislation; S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States; S. 525/H.R. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions regarding amending the federal food, drug and cosmetic act to allow the importation of prescription drugs by pharmacies; MedGuides regarding improvement needed to the Medication Guide Program no specific legislation; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish a workable rule that would allow for electronic prescribing of controlled substances no specific legislation; H.R. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to drug and device safety; H.R. 570 the Protecting Patients and Health Care Act of 2009 all provisions regarding nullifying regulations issued by the Secretary of Health and Human Services regarding conscience clause protections for health care workers and facilities; H.R. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals; S. 726/H.R. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. HR. 1256 the Family Smoking Prevention and Tobacco Control Act. Title II provisions relating to labeling and marketing of tobacco products, provisions relating to labeling and marketing of smokeless tobacco products, Title III provisions relating to the labeling, recordkeeping and records inspection of tobacco products. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

H.R. 1 the American Recovery and Reinvestment Act of 2009- Title IV, all provisions relating to Health Information Technology, Title V, all provisions relating to Medicaid FMAP; S. 391/HR. 1321 the Healthy Americans Act regarding the role of pharmacy in healthcare and Title VI regarding shared responsibilities; H.R. 816 the Military Retirees Health Care Protection Act, Section 3, all provisions relating to a prohibition on increasing the cost sharing requirement under the pharmacy benefits program and a prohibition on increasing premiums under TRICARE; Medicaid reimbursement for generic drugs relating to accurately defining Average Manufacturers Price (AMP) to reflect purchase price of retail pharmacies to ensure appropriate reimbursement no specific legislation; S. 80 the Pharmaceutical Market Access Act of 2009, all provisions; regarding amending the federal food, drug and cosmetic act to allow pharmacies to import qualifying drugs from certain countries into the United States; S. 525/H.R. 1298 the Pharmaceutical Market Access and Drug Safety Act of 2009 all provisions regarding amending the federal food, drug and cosmetic act to allow the importation of prescription drugs by pharmacies; MedGuides regarding improvement needed to the Medication Guide Program no specific legislation; Electronic Prescribing of Controlled Substances regarding the need for the DEA to publish a workable rule that would allow for electronic prescribing of controlled substances no specific legislation; H.R. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug and Device Safety all provisions relating to drug and device safety; H.R. 570 the Protecting Patients and Health Care Act of 2009 all provisions regarding nullifying regulations issued by the Secretary of Health and Human Services regarding conscience clause protections for health care workers and facilities; H.R. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals; S. 726/H.R. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biopharmaceuticals.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment; Medication Therapy Management (MTM) - program enhancements in the Medicare Modernization Act no specific legislation; H.R. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease; H.R. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement imposed on suppliers of durable medical equipment; H.R. 574/S. 254 - the "Medicare Home Infusion Therapy Coverage Act of 2009" - all provisions regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.

S.701/HR. 2002 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR. 3663 all provisions; regarding amending title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies.

S.701/HR. 2002 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR. 3663 all provisions; regarding amending title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies.

S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. HR. 1256 the Family Smoking Prevention and Tobacco Control Act. Title II provisions relating to labeling and marketing of tobacco products, provisions relating to labeling and marketing of smokeless tobacco products, Title III provisions relating to the labeling, recordkeeping and records inspection of tobacco products. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

H.R. 759 - the "Food and Drug Administration Globalization Act of 2009" - Title II - Drug and Device Safety - provisions relating to country of origin labeling for drugs and devices; H.R. 1815 the Consumer Product Safety Solutions Act Section 2 provisions relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provisions relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracking label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission.

HR 1259 the Dextromethorphan Distribution Act of 2009 all provisions of the bill; regarding amending the federal food, drug, and cosmetic act to limit the distribution and abuse of DXM. HR. 759 the Food and Drug Administration Globalization Act of 2009 Title II Drug Safety provisions relating to country of origin labeling for drugs and devices. HR. 1548 the Pathway for Biosimilars Act all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. S. 726/HR. 1427 the Promoting Innovation and Access to Life-Saving Medicine Act - all provisions; regarding establishing a pathway at the Food and Drug Administration for the approval of generic versions of biotech pharmaceuticals. HR. 1815 the Consumer Product Safety Solutions Act Section 2 provision relating to lead limits and third party testing requirements, Section 3 provisions relating to phthalates prohibition, Section 4 provisions relating to clarification of testing methodologies, Section 5 provisions relating to the exclusion of certain materials from lead content limit, Section 6 provision relating to the waiver of third party testing requirements for certain component parts, Section 7 provisions relating to exemptions from tracing label requirements, Section 8- provisions relating to the general application and exemptive authority of the Consumer Product Safety Commission. S. 882 the Drug and Device Accountability Act of 2009 Title I Ensuing the safety and quality of medical products and their components all provisions relating to this title on drug and device safety. S. 1383 the Dextromethorphan Abuse Reduction Act of 2009 all provisions; regarding amending the Controlled Substances Act to prevent the abuse of dextromethorphan.

S.701/HR. 2002 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR. 3663 all provisions; regarding amending title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies.

S.701/HR. 2002 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR. 3663 all provisions; regarding amending title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies.

S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.

S.701/HR. 2002 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR. 3663 all provisions; regarding amending title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies.

S.701/HR. 2002 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR. 3663 all provisions; regarding amending title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies.

S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.

S.701/HR. 2002 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR. 3663 all provisions; regarding amending title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies.

S.701/HR. 2002 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR. 3663 all provisions; regarding amending title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies.

S.701 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment; Medication Therapy Management (MTM) - program enhancements in the Medicare Modernization Act no specific legislation; H.R. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease; H.R. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement imposed on suppliers of durable medical equipment; H.R. 574/S. 254 - the "Medicare Home Infusion Therapy Coverage Act of 2009" - all provisions regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program.

Walgreens and its subsidiaries can impact efforts in health care reform with regards to access, affordability and quality. S. 1796, the Americas Healthy Future Act of 2009 regarding redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies as related to AMPs Federal Upper Limits (FULs), regarding expanding medication therapy management (MTM) services provided by pharmacists and expanding home infusion in Medicare to cover the supplies, equipment and services. S. 1679, the Affordable Health Choices Act - health care reform legislation introduced by Senator Edward Kennedy; regarding expanding medication therapy management (MTM) services provided by pharmacists also the establishment of a grant program to implement MTM for the treatment of chronic diseases. HR. 3200, the Americas Affordable Health Choices Act of 2009 regarding redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies as related to AMPs Federal Upper Limits (FULs), expanding home infusion in Medicare to cover the supplies, equipment and services, and regarding expanding medication therapy management (MTM) services provided by pharmacists. H.R. 3962, the Affordable Health Care for America Act- regarding redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies- as related to AMPs Federal Upper Limits (FULs), regarding expanding medication therapy management (MTM) services provided by pharmacists and expanding home infusion in Medicare to cover the supplies, equipment and services. HR 3590, the Patient Protection and Affordable Care Act- regarding redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies- as related to AMPs Federal Upper Limits (FULs), regarding expanding medication therapy management (MTM) services provided by pharmacists and expanding home infusion in Medicare to cover the supplies, equipment and services. HR 2350 the Preserving Patient Access to Primary Care Act of 2009 all provisions; regarding increasing the number of primary care physicians and primary care providers, such as nurse practitioners and physician assistants, to improve patient access to primary care services.

Walgreens and its subsidiaries can impact efforts in health care reform with regards to access, affordability and quality. Senate Finance Committee Health Reform Plan -Americas Healthy Future Act of 2009 regarding redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies as related to AMPs Federal Upper Limits (FULs), regarding expanding medication therapy management (MTM) services provided by pharmacists and expanding home infusion in Medicare to cover the supplies, equipment and services. S. 1679, the Affordable Health Choices Act - health care reform legislation introduced by Senator Edward Kennedy; regarding expanding medication therapy management (MTM) services provided by pharmacists also the establishment of a grant program to implement MTM for the treatment of chronic diseases. HR. 3200, the Americas Affordable Health Choices Act of 2009 regarding redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies as related to AMPs Federal Upper Limits (FULs), expanding home infusion in Medicare to cover the supplies, equipment and services, and regarding expanding medication therapy management (MTM) services provided by pharmacists. HR 2350 the Preserving Patient Access to Primary Care Act of 2009 all provisions; regarding increasing the number of primary care physicians and primary care providers, such as nurse practitioners and physician assistants, to improve patient access to primary care services.

Walgreens and its subsidiaries can impact efforts in health care reform with regards to access, affordability and quality. Senate Finance Policy Options Paper regarding redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies as related to AMPs Federal Upper Limits (FULs), regarding expanding medication therapy management (MTM) services provided by pharmacists and expanding home infusion in Medicare to cover the supplies, equipment and services, the role of nurse practioners, retail clinics and employer workite facilities in health care reform no specific legislation. American Health Choices Act draft health care reform legislation introduced by Senator Edward Kennedy; regarding expanding medication therapy management (MTM) services provided by pharmacists also the establishment of a grant program to implement MTM for the treatment of chronic diseases. House Tri-Committee Health Care Reform Draft regarding redefining Average Manufacturers Price (AMP) to further clarify the reimbursements to retail pharmacies as related to AMPs Federal Upper Limits (FULs), expanding home infusion in Medicare to cover the supplies, equipment and services, and regarding expanding medication therapy management (MTM) services provided by pharmacists. HR 2350 the Preserving Patient Access to Primary Care Act of 2009 all provisions; regarding increasing the number of primary care physicians and primary care providers, such as nurse practitioners and physician assistants, to improve patient access to primary care services.